Back

Genetic risk variants for heart failure onset and progression do not improve prediction of mortality beyond established prognostic neurohormonal and echocardiographic markers

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Biomarkers Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Anna Pilbrow

University of Otago Christchurch, Christchurch (New Zealand)

7 More presentations in this session

Presentation thumbnail
Myocardial fibrosis is reflected by two novel biomarkers of collagen formation in patients with cirrhosis: results from a prospective study with advanced cardiac MRI
Doctor A. Reese-Petersen (Copenhagen, DK)
Abstract
Presentation thumbnail
Age-related changes in the biomechanics of left ventricular twist are associated with accumulation of advanced glycation end-products and replicative senescence
Mrs E. Plokhova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Comparison of the effect of valsartan, eprosartan or losartan on N-terminal pro-brain natriuretic peptide plasma level and diastolic function in essential hypertension
Doctor L. Popescu (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Circulating microRNAs as selective markers of anthracyclines-based therapies in breast cancer patients
Ms S. Gioffre' (Milan, IT)
Abstract
Presentation thumbnail
Development of a qualitative and quantitative detection method for the N-terminal fragment of cardiac myosin-binding protein C
Doctor A. Yogeswaran (Giessen, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Biomarkers

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Congress Presentation
DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources